Skip to main content
Log in

RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

We optimized the assay for detection of cytokeratin 19 (CK19) mRNA by the reverse transcriptase-polymerase chain reaction (RT-PCR) in blood as an index of circulating tumor cells in breast cancer patients. The limit of detection of <1 MCF7 tumor cells per 106 peripheral blood leukocytes (PBL) was achieved in mixing experiments. We did not detect CKl9 mRNA in control bloods (0/30) or in the blood of patients with benign breast disease (0/15). In blood samples from 109 patients with invasive breast cancer, CK19 mRNA was detected in 7/23 patients with node-negative disease, in 21/58 with node-positive disease, and in 20/28 with distant metastases. There was a significant association (P<0.01) of CK19 positivity with distant metastatic versus both node-negative and node-positive disease, but not with any other histopathological parameter examined. In a small number of patients with distant metastases, increased intensity of the CK19 RT-PCR signal was associated with a reduced survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stasiak PC, Purkis PE, Leigh IM, Lane EB: Keratin 19: Predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 92: 707–716, 1989

    Google Scholar 

  2. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS: Sensitive detection of occult breast cancer by reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475–482, 1994

    Google Scholar 

  3. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, Coombes RC: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2886–2990, 1994

    Google Scholar 

  4. Peck K, Sher Y-P, Shih J-Y, Roffler SR, Wu C-W, Yang P-C: Detection and quantitation of circulating cancer cells in peripheral blood of lung cancer patients. Cancer Res 58: 2761–2765, 1998

    Google Scholar 

  5. Aihara T, Noguchi S, Ishikawa O, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M, Imaoka S: Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 72: 408–411, 1997

    Google Scholar 

  6. Yeh K-H, Chen Y-C, Yeh S-H, Chen C-P, Lin J-T, Cheng A-L: Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)-possible clinical significance in advanced gastric cancer. Anticancer Res 18: 1283–1286, 1998

    Google Scholar 

  7. Dingemans A-MC, Brakenhoff RH, Postmus PE, Giaccone G: Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest 77: 213–220, 1997

    Google Scholar 

  8. Page DL, Jensen RA, Simpson JF: Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat 51: 195–208, 1998

    Google Scholar 

  9. Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R: Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 80: 569–578, 1999

    Google Scholar 

  10. Chomczynski P, Sacchi N: A single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chioroform extraction. Anal Biochem 162: 156–159, 1987

    Google Scholar 

  11. Grandchamp B, De Verneuil H, Beaumont C, Chretien S, Walter O, Nordmann Y: Tissue-specific expression of porphobilinogen deaminase, two isoenzymes from a single gene. Eur J Biochem 162: 105–110, 1987

    Google Scholar 

  12. Chretien S, Dubart A, Beaupain D, Raich N, Grandchamp B, Rosa J, Gossens M, Romeo P-H: Alternative transcription and splicing of the human porphobilinogen deaminase gene resulting either in tissue-specific or in housekeeping gene expression. Proc Natl Acad Sci USA 85: 6–10, 1988

    Google Scholar 

  13. Savtchenko ES, Schiff TA, Jiang C-K, Freedberg IM, Blumenberg M: Embryonic expression of human 40-kD keratin: evidence from a processed pseudogene sequence. Am J Hum Genet 43: 630–637, 1988

    Google Scholar 

  14. Mansi JL, Easton D, Berger U, Gazet J-C, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years follow-up. Eur J Cancer 27: 1552–1555, 1991

    Google Scholar 

  15. Cote RJ, Rose PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micromestastases. J Clin Oncol 9: 1749–1756, 1991

    Google Scholar 

  16. Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer: long-term follow-up of the first patient cohort. Eur J Cancer 27: 236–239, 1991

    Google Scholar 

  17. Ménard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi P, Salvadori B, Veronesi U, Colnaghi MI: Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. Br J Cancer 69: 1126–1129, 1994

    Google Scholar 

  18. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14: 1868–1876, 1996

    Google Scholar 

  19. Krüger W, Krzizanowski C, Holweg M, Stockschläder M, Kröger N, Jung R, Mross K, Jonat W, Zander AR: Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122: 679–689, 1996

    Google Scholar 

  20. Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet J-C, Sacks N, Bender HG, Luqmani Y, Coombes RC: The detection of micromestastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33: 854–861, 1997

    Google Scholar 

  21. Slade MJ, Smith BM, Sinnett HD, Cross NCP, Coombes RC: Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 17: 870–879, 1999

    Google Scholar 

  22. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DSB: Limitations of specific reverse transcriptase-polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632–2640, 1998

    Google Scholar 

  23. Brossart P, Schmier J-W, Krüger S, Willhauck M, Scheibenbogen C, Möhler T, Keilholz U: A polymerase chain reactionbased semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55: 4065–4068, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kahn, H.J., Yang, LY., Blondal, J. et al. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters. Breast Cancer Res Treat 60, 143–151 (2000). https://doi.org/10.1023/A:1006350913243

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006350913243

Navigation